Unknown

Dataset Information

0

SABR-COMET: a new paradigm of care lights up the twilight of metastatic disease.

ABSTRACT:

SUBMITTER: Sogono P 

PROVIDER: S-EPMC6944625 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

SABR-COMET: a new paradigm of care lights up the twilight of metastatic disease.

Sogono Paolo P   Ball David L DL   Siva Shankar S  

Annals of translational medicine 20191101 22

Similar Datasets

Unknown Signals from SABR-COMET time to move on to phase III studies.
| S-EPMC6976417 | biostudies-literature
Unknown Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5.
| S-EPMC6172706 | biostudies-literature
Unknown Telomere G-triplex lights up Thioflavin T for RNA detection: new wine in an old bottle.
| S-EPMC9208972 | biostudies-literature
Unknown Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.
| S-EPMC3433376 | biostudies-literature
Unknown Bridging population and tissue scale tumor dynamics: a new paradigm for understanding differences in tumor growth and metastatic disease.
| S-EPMC3913019 | biostudies-literature
Unknown The magic of bicelles lights up membrane protein structure.
| S-EPMC3497859 | biostudies-literature
Unknown Photonic matrix multiplication lights up photonic accelerator and beyond.
| S-EPMC8814250 | biostudies-literature
Unknown Pelvic stereotactic ablative body radiotherapy (SABR) reirradiation: UK SABR consortium guidance for use in routine clinical care.
| S-EPMC12356378 | biostudies-literature
Genomics COMET
| PRJEB28123 | ENA
Unknown Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial.
| S-EPMC7460150 | biostudies-literature